Most Read Articles
Stephen Padilla, 05 Jan 2018
The addition of an antihypertensive drug from a new class to a patient’s regimen results in huge decreases in systolic blood pressure (SBP) and major cardiovascular (CV) events among those at high risk for CV events but without diabetes, suggests a recent study. Its effects on SBP remain large and similar in magnitude across all levels of baseline drug use and all subgroups of patients.
Pearl Toh, 3 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
04 Jan 2018
Thromboembolism is a major cause of death in patients with cancer, which is why clinicians should check for the symptoms of thromboembolic events right from the initial stages of bevacizumab treatment, suggests a recent study.
04 Jan 2018
Statins appear to reduce the severity of acute pancreatitis (AP), as demonstrated by a decrease in overall incidence of multisystem organ failure (MSOF), according to a study.

Time spent managing disease, annual testing predict satisfaction in coeliac disease patients

07 Jan 2018
Savvy physicians should take advantage of these resources to deliver a message that presents their practices in the best light.

A recent survey has shown that coeliac disease (CD) care is satisfactory for a majority of patients who report higher approval when they feel physicians spend time caring for their CD needs and when they receive annual CD-antibody testing.

“On the basis of our study, these factors are more important than disease severity, seeing a CD specialist, and quality of life in determining patient satisfaction with CD care,” the authors said.

Of the 387 individuals (22 percent) who completed the survey, 229 met the inclusion criteria of biopsy-proven CD. With regard to their CD care, a total of 79 participants (34.5 percent) reported being “very satisfied,” 82 (35.8 percent) “satisfied,” 46 (20.1 percent) “neutral,” 14 (6.1 percent) “dissatisfied,” and eight (3.5 percent) “very dissatisfied.”

Multivariable analysis revealed that physicians spending ample time managing CD needs of patients (p=0.013) and having CD-antibody levels monitored every year positively predicted patient satisfaction. On the other hand, symptom severity (p=0.268), quality of life (p=0.13), and following with a CD specialist (p=0.139) did not correlate with patient satisfaction.

To assess how satisfied patients were with their CD care and to determine factors influencing satisfaction, the authors distributed an online questionnaire to adults receiving programmatic updates from a CD referral centre. The survey focused on aspects of CD care and used disease-specific validated instruments to measure quality of life and dietary adherence.

The authors also conducted univariable and multivariable analyses with the use of satisfaction as a binary outcome comparing grouped “satisfied” and “very satisfied” respondents to “neutral,” “dissatisfied,” and “very dissatisfied” respondents.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Stephen Padilla, 05 Jan 2018
The addition of an antihypertensive drug from a new class to a patient’s regimen results in huge decreases in systolic blood pressure (SBP) and major cardiovascular (CV) events among those at high risk for CV events but without diabetes, suggests a recent study. Its effects on SBP remain large and similar in magnitude across all levels of baseline drug use and all subgroups of patients.
Pearl Toh, 3 days ago
A study finds no evidence that using pharmaceutical aids alone for smoking cessation helps improve the chances of successful quitting despite promising results in previous randomized trials and routine prescription of such drugs to help quit smoking.
04 Jan 2018
Thromboembolism is a major cause of death in patients with cancer, which is why clinicians should check for the symptoms of thromboembolic events right from the initial stages of bevacizumab treatment, suggests a recent study.
04 Jan 2018
Statins appear to reduce the severity of acute pancreatitis (AP), as demonstrated by a decrease in overall incidence of multisystem organ failure (MSOF), according to a study.